| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, Prisma Group International journal of surgery 8 (5), 336-341, 2010 | 14304* | 2010 |
| Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ... The Lancet infectious diseases 18 (3), 318-327, 2018 | 4999 | 2018 |
| Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results WHO Solidarity Trial Consortium New England journal of medicine 384 (6), 497-511, 2021 | 2641 | 2021 |
| Practice guidelines developed by specialty societies: the need for a critical appraisal R Grilli, N Magrini, A Penna, G Mura, A Liberati The Lancet 355 (9198), 103-106, 2000 | 913 | 2000 |
| Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development E Tacconelli ICAN: Infection Control Africa Network, 2017 | 888 | 2017 |
| What is antimicrobial stewardship? OJ Dyar, B Huttner, J Schouten, C Pulcini Clinical microbiology and infection 23 (11), 793-798, 2017 | 680 | 2017 |
| Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries B Huttner, H Goossens, T Verheij, S Harbarth The Lancet infectious diseases 10 (1), 17-31, 2010 | 503 | 2010 |
| Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system D Atkins, PA Briss, M Eccles, S Flottorp, GH Guyatt, RT Harbour, S Hill, ... BMC health services research 5, 1-12, 2005 | 449 | 2005 |
| COVID-19: don't neglect antimicrobial stewardship principles! BD Huttner, G Catho, JR Pano-Pardo, C Pulcini, J Schouten Clinical Microbiology and Infection 26 (7), 808-810, 2020 | 434 | 2020 |
| Meta-analysis: Duration of First-Line Proton-Pump Inhibitor–Based Triple Therapy for Helicobacter pylori Eradication L Fuccio, ME Minardi, RM Zagari, D Grilli, N Magrini, F Bazzoli Annals of internal medicine 147 (8), 553-562, 2007 | 348 | 2007 |
| Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe M Sharland, C Pulcini, S Harbarth, M Zeng, S Gandra, S Mathur, ... The Lancet Infectious Diseases 18 (1), 18-20, 2018 | 288 | 2018 |
| Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries Y Hsia, BR Lee, A Versporten, Y Yang, J Bielicki, C Jackson, J Newland, ... The Lancet Global Health 7 (7), e861-e871, 2019 | 268 | 2019 |
| Combined effects of polarization mode dispersion and polarization dependent losses in optical fibers N Gisin, B Huttner Optics communications 142 (1-3), 119-125, 1997 | 268 | 1997 |
| Short‐term and long‐term effects of tibolone in postmenopausal women G Formoso, E Perrone, S Maltoni, S Balduzzi, J Wilkinson, V Basevi, ... Cochrane Database of Systematic Reviews, 2016 | 249 | 2016 |
| An emerging consensus on grading recommendations? G Guyatt, G Vist, Y Falck-Ytter, R Kunz, N Magrini, H Schunemann BMJ Evidence-Based Medicine 11 (1), 2-4, 2006 | 229 | 2006 |
| Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study A Huttner, E Von Dach, A Renzoni, BD Huttner, M Affaticati, L Pagani, ... International journal of antimicrobial agents 45 (4), 385-392, 2015 | 217 | 2015 |
| A PEST-like element in FREQUENCY determines the length of the circadian period in Neurospora crassa M Görl, M Merrow, B Huttner, J Johnson, T Roenneberg, M Brunner The EMBO Journal 20 (24), 7074-7084, 2001 | 208 | 2001 |
| Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle … Y Hsia, M Sharland, C Jackson, ICK Wong, N Magrini, JA Bielicki The Lancet Infectious Diseases 19 (1), 67-75, 2019 | 183 | 2019 |
| Effect of C-reactive protein–guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram … E von Dach, WC Albrich, AS Brunel, V Prendki, C Cuvelier, D Flury, ... Jama 323 (21), 2160-2169, 2020 | 179 | 2020 |
| ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers E Tacconelli, F Mazzaferri, AM de Smet, D Bragantini, P Eggimann, ... Clinical microbiology and infection 25 (7), 807-817, 2019 | 174 | 2019 |
